PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Pediatric Infectious Diseases Research Center, Communicable Diseases Institute, Mazandaran University of Medical Sciences, Sari, Iran.\', \'Antimicrobial Resistance Research Center, Department of Infectious Diseases, Communicable Diseases Institute, Mazandaran University of Medical Sciences, Sari, Iran.\', \'Department of Clinical Pharmacy, Faculty of Pharmacy, Cardiovascular Research Center, Mazandaran University of Medical Sciences, Sari, Iran.\', \'Department of Pharmacotherapy and Translational Research, Center for Pharmacogenomics and Precision Medicine, University of Florida, Gainesville, Florida.\', \'Student Research Committee, Mazandaran University of Medical Sciences, Sari, Iran.\', \'Pediatric Infectious Diseases Research Center, Communicable Diseases Institute, Mazandaran University of Medical Sciences, Sari, Iran. Electronic address: drmsrezaii@yahoo.com.\']
?:citedBy
  • -1
?:creator
?:doi
  • S0149-2918(21)00201-010.1016/j.clinthera.2021.04.007
?:doi
?:hasPublicationType
?:journal
  • Clinical therapeutics
is ?:pmid of
?:pmid
?:pmid
  • 34052007
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.151
?:rankingScore_hIndex
  • 120
is ?:relation_isRelatedTo_publication of
?:title
  • Effects of Ivermectin in Patients With COVID-19: A Multicenter, Double-blind, Randomized, Controlled Clinical Trial.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all